About 11 results found for searched term "D-Mannose" (0.132 seconds)
Cat.No. | Name | Target |
---|---|---|
M9226 | D-Mannose | Others |
D-Mannose is a carbohydrate, which plays an important role in human metabolism, especially in the glycosylation of specific proteins. | ||
M40903 | DSPE-PEG2000-Mannose | Solvents & Excipients |
DSPE- PEG2000-MAN | ||
DSPE-PEG2000-Mannose is a functional molecule commonly used in biomedical research for studies related to nanodrug delivery systems or cellular recognition. | ||
M57549 | 2-[(Azidoacety)amino]-2-deoxy-D-mannose | Others |
2-[(Azidoacety)amino]-2-deoxy-D-mannose | ||
M14438 | Castanospermine | Others |
Castanospermine inhibits all forms of α- and β-glucosidases, especially glucosidase l (required for glucoprotein processing by transfer of mannose and glucose from asparagine-linked lipids). | ||
M20450 | Methyl α-D-mannopyranoside | Others |
Methyl α-D-mannopyranoside can be used as an intermediate for chemical sythesis and is a competitor inhibitor of the binding of mannose by Escherichia coli. | ||
M24949 | Clervonafusp alfa | Others |
VAL-1221 | ||
Clervonafusp alfa (VAL-1221) is a fusion protein targeting both cytosolic and lysosomal glycogen. Clervonafusp alfa is comprised of the Fab portion of a cell-penetrating antibody and recombinant human acid alpha glucosidase (rhGAA), the former utilizing the nucleoside transporter ENT-2 to gain access to the cytosol, and the latter enters lysosomes via mannose-6-phosphate receptors (M6PRs). Clervonafusp alfa can be used for late-onset Pompe disease research. | ||
M25525 | Thyroglobulin (from bovine thyroid) | Animal Modeling |
Thyroglobulin is an excellent source of N-linked glycans of various structures, including sialylated core fucose and oligomannose oligosaccharides. Native thyroglobulin, consisting of two polypeptide homodimers of 330 kDa each, purified from bovine thyroid. | ||
M27790 | Kifunensine | Others |
FR-900494 | ||
Kifunensine, a potent and selective inhibitor of class I α-mannosidases isolated from Actinomycete, prevents α-mannosidases I from trimming mannose residues on glycoproteins. Kifunensine inhibits ERAD. | ||
M43839 | ML089 | Others |
ML089 is an orally active, potent, and selective phosphomannose isomerase (PMI) inhibitor with an IC50 value of 1.3 µM for studies related to congenital disorders of glycosylation. | ||
M52588 | β-Mannosidase | Metabolite/Endogenous Metabolite |
β-Mannosidase is a lysosomal enzyme from the glycosyl hydrolase family 2 that cleaves the single β(1-4)-linked mannose at the nonreducing end of N-glycosylated proteins. | ||
M58181 | Recombinant Mouse C3a (E. coli) | Cytokines and Growth Factors |
Complement Component C3a; Anaphylatoxin | ||
Complement 3 (C3) is the most abundant component of the complement cascade and the convergent point for all three major complement activation pathways: namely classical, alternative and mannose-binding lectin pathways. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.